The rapid emergence of resistance to classical antibiotics has increased the interest in novel antimicrobial compounds. Antimicrobial peptides (AMPs) represent an attractive alternative to classical antibiotics and a number of different studies have reported antimicrobial activity data of various AMPs， but there is only limited comparative data available. The mode of action for many AMPs is largely unknown even though several models have suggested that the lipopolysaccharides (LPS) play a crucial role in the attraction and attachment of the AMP to the bacterial membrane in Gram-negative bacteria. We compared the potency of Cap18， Cap11， Cap11-1-18m2， Cecropin P1， Cecropin B， Bac2A， Bac2A-NH2， Su... More
The rapid emergence of resistance to classical antibiotics has increased the interest in novel antimicrobial compounds. Antimicrobial peptides (AMPs) represent an attractive alternative to classical antibiotics and a number of different studies have reported antimicrobial activity data of various AMPs， but there is only limited comparative data available. The mode of action for many AMPs is largely unknown even though several models have suggested that the lipopolysaccharides (LPS) play a crucial role in the attraction and attachment of the AMP to the bacterial membrane in Gram-negative bacteria. We compared the potency of Cap18， Cap11， Cap11-1-18m2， Cecropin P1， Cecropin B， Bac2A， Bac2A-NH2， Sub5-NH2， Indolicidin， Melittin， Myxinidin， Myxinidin-NH2， Pyrrhocoricin， Apidaecin and Metalnikowin I towards Staphylococcus aureus， Enterococcus faecalis， Pseudomonas aeruginosa， Escherichia coli， Aeromonas salmonicida， Listeria monocytogenes， Campylobacter jejuni， Flavobacterium psychrophilum， Salmonella typhimurium and Yersinia ruckeri by minimal inhibitory concentration (MIC) determinations. Additional characteristics such as cytotoxicity， thermo and protease stability were measured and compared among the different peptides. Further， the antimicrobial activity of a selection of cationic AMPs was investigated in various E. coli LPS mutants.
